Integrated Management of Atypical Parkinsonism - Home-Based Care (NCT05792332)

Overview

Overview

This study evaluates a comprehensive, patient-centered home-based care management program for patients with atypical Parkinsonian syndromes, focusing on improving quality of life, reducing hospitalizations, and optimizing functional independence["@nct"]. Atypical Parkinsonian syndromes (APS) represent a group of neurodegenerative disorders that share features with [Parkinson's Disease](/diseases/parkinsons-disease) but typically progress more rapidly and respond less favorably to dopaminergic medications["PSP_nih"].

The trial addresses a critical gap in neurological care: while significant research focuses on disease-modifying therapies, there remains a substantial unmet need in optimizing day-to-day management of patients with progressive neurodegnerative conditions. The integrated care model recognizes that comprehensive support services can significantly impact patient outcomes even in the absence of curative treatments.

Study Details

| Field | Value |
|-------|-------|
| NCT ID | NCT05792332 |
| Status | Recruiting |
| Study Type | Interventional |
| Study Design | Parallel assignment, single-blind |
| Conditions | PSP, MSA, CBS, Atypical Parkinsonism |
| Intervention | Home-based comprehensive care management |
| Age Range | 18 years and older |
| Enrollment | Target enrollment specified in trial registry |
| Primary Sponsor | Academic medical center |

Disease Conditions Studied

Progressive Supranuclear Palsy (PSP)

[PSP](/diseases/progressive-supranuclear-palsy) is a rare neurodegenerative disorder characterized by:

• Vertical gaze palsy — difficulty moving eyes vertically
• Postural instability — early and frequent falls
• Parkinsonism — bradykinesia, rigidity
• Cognitive decline — frontal lobe dysfunction

• PSP with parkinsonism (PSP-P)
• PSP with pure akinesia and gait freezing (PSP-PAGF)
• PSP with corticobasal syndrome (PSP-CBS)

Multiple System Atrophy (MSA)

[MSA](/diseases/multiple-system-atrophy) encompasses two main subtypes:

• MSA-P (predominantly parkinsonian): Features include parkinsonism, autonomic dysfunction
• MSA-C (predominantly cerebellar): Features include ataxia, cerebellar signs

• Autonomic failure — orthostatic hypotension, urinary dysfunction
• Cerebellar signs — gait ataxia, nystagmus
• Parkinsonism — poor levodopa response
• Rapid progression — typically 5-9 years from onset to death

Corticobasal Syndrome (CBS)

[CBS](/diseases/corticobasal-syndrome) represents a heterogeneous disorder with:

• Asymmetric parkinsonism — typically affects one side initially
• Cortical sensory loss — astereognosis, neglect
• Apraxia — difficulty with learned motor tasks
• Alien limb phenomena — involuntary limb movements
• Cognitive decline — progressive aphasia, executive dysfunction

Scientific Rationale

Challenges in Atypical Parkinsonian Syndromes

Atypical Parkinsonian syndromes (APS) present unique challenges that differ substantially from [Parkinson's Disease](/diseases/parkinsons-disease)[@psp_nih][@msa_Overview][@cbs_Overview]:

Disease Progression

• Rapid progression: Mean survival 5-8 years from diagnosis, versus 15-20 years in PD
• Early disability: Loss of ambulation typically occurs within 3-5 years
• Multisystem involvement: Motor, autonomic, cognitive, and behavioral symptoms

Treatment Limitations

• Poor medication response: Limited benefit from levodopa compared to PD
• Complex regimens: Multiple medications for various symptoms
• Adverse effects: Sensitivity to medications, particularly antipsychotics

Care Needs

• Complex care coordination: Multiple specialists (neurology, cardiology, urology, psychiatry)
• Equipment needs: Mobility aids, communication devices, home modifications
• 24-hour supervision: Progressive need for caregiver assistance

Care Challenges

The comprehensive care model addresses multiple challenges[integrated_care_neuro][caregiver_burden]:

• Multiple daily medications for motor and non-motor symptoms
• Timing dependencies (levodopa dosing intervals)
• Drug interactions requiring careful management
• Financial burden of multiple medications

• Coordination across multiple healthcare systems
• Transportation challenges as disease progresses
• Communication between providers
• Appointment scheduling complexity

• Loss of independence in activities of daily living
• Fall risk increasing with disease progression
• Communication difficulties
• Swallowing and nutrition challenges

• Physical demands of assistance with daily activities
• Emotional and psychological stress
• Financial burden of care-related costs
• Social isolation and role changes

• Caregiver burnout leading to nursing home placement
• Medical crises requiring hospitalization
• Safety concerns at home
• Financial considerations

Integrated Care Models

Evidence supports the efficacy of integrated care approaches[integrated_care_neuro][telehealth_neuro]:

• Multidisciplinary team approach
• Unified care planning
• Shared decision-making

• In-home therapy services
• Environmental modifications
• Personalized care plans

• Remote symptom tracking
• Medication adherence support
• Virtual check-ins

• Education and training
• Respite services
• Support groups

• Anticipatory guidance
• Early intervention for complications
• Advance care planning

Study Objectives

Primary Endpoints

The trial measures several key outcomes:

• PDQ-39 (Parkinson's Disease Questionnaire-39)
• Caregiver burden scales (Zarit Burden Interview)
• Health utility measures

• Hospitalization rates and frequency
• Emergency department visits
• Outpatient visit patterns

• Falls frequency and severity
• Time to first fall
• Fall-related injuries

• Medication compliance rates
• Appointment attendance
• Protocol adherence

Secondary Endpoints

Secondary outcomes include[home_rehab][fall_prevention]:

• ADL (Activities of Daily Living) scores
• IADL (Instrumental ADL) measures
• Functional Independence Measure (FIM)

• Time to institutionalization
• Progression to wheelchair dependence
• Development of new complications

• Satisfaction questionnaires
• Quality of care measures
• Care experience ratings

• Cost-effectiveness analysis
• Healthcare cost comparison
• Resource utilization patterns

Intervention Components

1. Care Coordination

The care coordination component provides[@integrated_care_neuro]:

• Dedicated care manager
• Single point of contact for all care needs
• Navigation assistance through healthcare system
• Advocacy for patient and family
• Regular phone/video check-ins
• Weekly scheduled touchpoints
• As-needed support between scheduled calls
• 24/7 availability for urgent concerns
• Medication reconciliation
• Regular review of all medications
• Identification of interactions
• Optimization of dosing schedules
• Cost-containment strategies
• Appointment scheduling
• Coordination of specialist appointments
• Transportation arrangements
• Pre-visit preparation

2. Home Safety Assessment

Home safety interventions include[@home_rehab][fall_prevention]:

• Fall risk evaluation
• Comprehensive home safety audit
• Identification of environmental hazards
• Balance and gait assessment
• Home modification recommendations
• Bathroom modifications (grab bars, shower chairs)
• Lighting improvements
• Furniture arrangement optimization
• Floor surface management
• Assistive device provision
• Walkers, wheelchairs, transfer devices
• Communication aids
• Adaptive equipment for daily activities
• Caregiver training
• Safe transfer techniques
• Fall prevention strategies
• Emergency response procedures

3. Telehealth Monitoring

Technology-enabled monitoring provides[telehealth_neuro]:

• Vital sign tracking
• Blood pressure monitoring (critical for MSA)
• Heart rate variability
• Weight monitoring
• Symptom reporting
• Motor symptom tracking
• Non-motor symptom logs
• Side effect documentation
• Medication reminders
• Automated dosing reminders
• Refill notifications
• Compliance tracking
• Exercise compliance
• Home exercise program monitoring
• Physical therapy adherence
• Daily activity tracking

4. Education and Support

Patient and caregiver education covers:

• Disease education
• Understanding disease progression
• Symptom management strategies
• Medication knowledge
• Coping strategies
• Behavioral management techniques
• Stress reduction methods
• Communication strategies
• Advance care planning
• Goals of care discussions
• Advance directive completion
• Legal planning (power of attorney, living will)
• Support groups
• Patient support groups
• Caregiver support networks
• Community resources

Disease-Specific Considerations

Relevance to PSP

[PSP](/diseases/progressive-supranuclear-palsy) patients particularly benefit from integrated care because[psp_nih]:

• Early falls require immediate home safety interventions
• Environmental modifications prevent injuries
• Mobility aids preserve independence
• Caregiver training enables safe assistance
• Progressive disability needs anticipatory planning
• Equipment needs evolve as disease progresses
• Care needs increase over time
• Financial planning addresses long-term needs
• Cognitive changes affect treatment adherence
• Caregiver involvement ensures compliance
• Simplified medication regimens improve adherence
• Regular monitoring identifies issues early
• Caregiver support is essential
• High burden requires proactive support
• Respite prevents burnout
• Education improves care quality

Relevance to MSA

[MSA](/diseases/multiple-system-atrophy) patients benefit from[msa_Overview]:

• Autonomic management
• Blood pressure monitoring and management
• Urinary catheter care if needed
• Swallowing assessment
• Cardiovascular protection
• Fluid and salt intake protocols
• Compression garment use
• Graduated position changes
• Respiratory monitoring
• Sleep-disordered breathing assessment
• Pneumonia prevention
• Early intervention for complications

Relevance to CBS

[CBS](/diseases/corticobasal-syndrome) patients require[cbs_Overview]:

• Asymmetric care needs
• Equipment adapted to affected side
• Environmental modifications for unilateral deficits
• Communication support
• Augmentative communication devices
• Speech therapy integration
• Cognitive support
• Structured daily routines
• Environmental cues
• Behavioral management strategies

Expected Outcomes

The integrated care model anticipates[integrated_care_neuro][caregiver_burden]:

• Fewer emergency department visits
• Reduced hospitalization rates
• Shorter hospital stays when required

• Better symptom management
• Enhanced functional independence
• Improved psychological well-being

• Extended time at home
• Reduced nursing home placement
• Caregiver sustainability improved

• Improved coping skills
• Better support systems
• Enhanced quality of life

• Reduced healthcare costs
• Delayed long-term care expenses
• Optimized resource utilization

Comparison with Standard Care

| Outcome | Standard Care | Integrated Care |
|---------|--------------|-----------------|
| Annual hospitalizations | 2-3 per year | Expected reduction |
| Fall rate | 60-70% annually | Expected reduction |
| Time to nursing home | 3-5 years | Expected extension |
| Caregiver burden | High | Moderate |
| Quality of life | Variable | Expected improvement |

Implementation Considerations

Staff Requirements

• Care coordinators (1:30 patient ratio)
• Physical therapists for home assessments
• Telehealth support staff
• Administrative support

Technology Requirements

• Video conferencing platform (HIPAA-compliant)
• Remote monitoring devices
• Electronic health record integration
• Patient portal access

Cost Considerations

• Initial investment in infrastructure
• Staff training and development
• Ongoing operational costs
• Reimbursement models

Future Directions

This trial will inform:

Cross-References

Related Diseases

• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
• [Parkinson's Disease](/diseases/parkinsons-disease)

Related Topics

• [PSP Quality of Life](/diseases/psp-quality-of-life)
• [Caregiver Support in Neurodegeneration](/diseases/caregiver-burden-corticobasal-syndrome)](/diseases/neurodegeneration)
• [Home-Based Rehabilitation](/therapeutics/home-based-rehabilitation)](/therapeutics)
• [Fall Prevention in PSP](/diseases/falls-in-psp)
• [Telehealth in Movement Disorders](/therapeutics/telehealth-parkinsons)

Clinical Trials

• [PSP Clinical Trials Overview](/clinical-trials/psp-clinical-trials)](/clinical-trials)
• [MSA Clinical Trials Overview](/clinical-trials/msa-clinical-trials)](/clinical-trials)
• [CBS Clinical Trials Overview](/clinical-trials/cbs-clinical-trials)

References